170 related articles for article (PubMed ID: 23331767)
21. Risk of acute kidney injury after transarterial chemoembolisation in hepatocellular carcinoma patients: A nationwide population-based cohort study.
Lee BC; Liu KL; Lin CL; Kao CH
Eur Radiol; 2017 Nov; 27(11):4482-4489. PubMed ID: 28593432
[TBL] [Abstract][Full Text] [Related]
22. Risk of second primary cancers in individuals diagnosed with index smoking- and non-smoking- related cancers.
Adjei Boakye E; Wang M; Sharma A; Jenkins WD; Osazuwa-Peters N; Chen B; Lee M; Schootman M
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1765-1779. PubMed ID: 32356175
[TBL] [Abstract][Full Text] [Related]
23. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.
Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA
J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276
[TBL] [Abstract][Full Text] [Related]
24. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.
Chien J; Liu J; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Yang HI; Chen CJ
J Gastroenterol Hepatol; 2016 Dec; 31(12):1971-1977. PubMed ID: 27118149
[TBL] [Abstract][Full Text] [Related]
25. Second primary malignancy risk among patients with gastric cancer: a nationwide population-based study in Taiwan.
Chen SC; Liu CJ; Hu YW; Yeh CM; Hu LY; Wang YP; Hung YP; Tzeng CH; Chiou TJ; Chen TJ; Teng CJ
Gastric Cancer; 2016 Apr; 19(2):490-497. PubMed ID: 25772342
[TBL] [Abstract][Full Text] [Related]
26. Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation-wide cohort study.
Huang YW; Wang TC; Yang SS; Lin SY; Fu SC; Hu JT; Liu CJ; Kao JH; Chen DS
Aliment Pharmacol Ther; 2015 Oct; 42(7):902-11. PubMed ID: 26211742
[TBL] [Abstract][Full Text] [Related]
27. Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is needed.
Hong TP; Gow P; Fink M; Dev A; Roberts S; Nicoll A; Lubel J; Kronborg I; Arachchi N; Ryan M; Kemp W; Knight V; Farrugia H; Thursfield V; Desmond P; Thompson AJ; Bell S
Hepatology; 2016 Apr; 63(4):1205-12. PubMed ID: 26435297
[TBL] [Abstract][Full Text] [Related]
28. Second Primary Cancer Risk among Kidney Cancer Patients in Korea: A Population-Based Cohort Study.
Joung JY; Kwon WA; Lim J; Oh CM; Jung KW; Kim SH; Seo HK; Park WS; Chung J; Lee KH; Won YJ
Cancer Res Treat; 2018 Jan; 50(1):293-301. PubMed ID: 28421722
[TBL] [Abstract][Full Text] [Related]
29. Trends in the risk of second primary cancer among bladder cancer survivors: a population-based cohort of 10 047 patients.
Muller J; Grosclaude P; Lapôtre-Ledoux B; Woronoff AS; Guizard AV; Bara S; Colonna M; Troussard X; Bouvier V; Trétarre B; Velten M; Jégu J
BJU Int; 2016 Jul; 118(1):53-9. PubMed ID: 26469096
[TBL] [Abstract][Full Text] [Related]
30. The effect of patient characteristics on second primary cancer risk in France.
Jégu J; Colonna M; Daubisse-Marliac L; Trétarre B; Ganry O; Guizard AV; Bara S; Troussard X; Bouvier V; Woronoff AS; Velten M
BMC Cancer; 2014 Feb; 14():94. PubMed ID: 24528929
[TBL] [Abstract][Full Text] [Related]
31. Optimal treatment increased survival of hepatocellular carcinoma patients detected with community-based screening.
Tseng PL; Wang JH; Tung HD; Hung CH; Kee KM; Chen CH; Chang KC; Lee CM; Changchien CS; Chen PF; Tsai LS; Lu SN
J Gastroenterol Hepatol; 2010 Aug; 25(8):1426-34. PubMed ID: 20659234
[TBL] [Abstract][Full Text] [Related]
32. Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection.
Lai MS; Hsieh MS; Chiu YH; Chen TH
Hepatology; 2006 Jun; 43(6):1295-302. PubMed ID: 16729295
[TBL] [Abstract][Full Text] [Related]
33. Fine Particle Pollution, Alanine Transaminase, and Liver Cancer: A Taiwanese Prospective Cohort Study (REVEAL-HBV).
Pan WC; Wu CD; Chen MJ; Huang YT; Chen CJ; Su HJ; Yang HI
J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26561636
[TBL] [Abstract][Full Text] [Related]
34. Pelvic inflammatory disease increases the risk of a second primary malignancy in patients with cervical cancer treated by surgery alone.
Chiou WY; Chen CA; Lee MS; Lin HY; Li CY; Su YC; Tsai SJ; Hung SK
Medicine (Baltimore); 2016 Nov; 95(47):e5409. PubMed ID: 27893679
[TBL] [Abstract][Full Text] [Related]
35. Second primary cancer after intensity-modulated radiotherapy for nasopharyngeal carcinoma: A territory-wide study by HKNPCSG.
Chow JCH; Tam AHP; Cheung KM; Lee VHF; Chiang CL; Tong M; Wong ECY; Cheung AKW; Chan SPC; Lai JWY; Ngan RKC; Ng WT; Lee AWM; Au KH
Oral Oncol; 2020 Dec; 111():105012. PubMed ID: 32980659
[TBL] [Abstract][Full Text] [Related]
36. Factors that affect risk for hepatocellular carcinoma and effects of surveillance.
Yang JD; Harmsen WS; Slettedahl SW; Chaiteerakij R; Enders FT; Therneau TM; Orsini L; Kim WR; Roberts LR
Clin Gastroenterol Hepatol; 2011 Jul; 9(7):617-23.e1. PubMed ID: 21459158
[TBL] [Abstract][Full Text] [Related]
37. Risks of female genital tract related cancers (gynecological cancers) or breast cancer in women with and without chronic kidney disease: A population-based cohort study in Taiwan.
Chang WH; Horng HC; Yeh CC; Guo CY; Chou YJ; Huang N; Huang HY; Chen YJ; Lee WL; Wang PH
Medicine (Baltimore); 2018 Mar; 97(12):e0157. PubMed ID: 29561423
[TBL] [Abstract][Full Text] [Related]
38. Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenofovir.
Hsu YC; Ho HJ; Lee TY; Huang YT; Wu MS; Lin JT; Wu CY; El-Serag HB
J Viral Hepat; 2018 May; 25(5):543-551. PubMed ID: 29193536
[TBL] [Abstract][Full Text] [Related]
39. Factors associated with hepatocellular carcinoma occurrence after HCV eradication in patients without cirrhosis or with compensated cirrhosis.
Abe K; Wakabayashi H; Nakayama H; Suzuki T; Kuroda M; Yoshida N; Tojo J; Kogure A; Rai T; Saito H; Mukai S; Fujita M; Hayashi M; Takahashi A; Ohira H
PLoS One; 2020; 15(12):e0243473. PubMed ID: 33284844
[TBL] [Abstract][Full Text] [Related]
40. Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study.
Lai SW; Chen PC; Liao KF; Muo CH; Lin CC; Sung FC
Am J Gastroenterol; 2012 Jan; 107(1):46-52. PubMed ID: 22085817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
